LAVA Therapeutics
LVTX
LVTX
15 hedge funds and large institutions have $11.7M invested in LAVA Therapeutics in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
-4
Holders Change %
-21.05%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
2
Closed
9
Calls
$35K
Puts
–
Net Calls
+$35K
Net Calls Change
+$35K
Top Buyers
| 1 |
BC
Bruce & Co
Chicago,
Illinois
|
+$203K |
| 2 |
Millennium Management
New York
|
+$163K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$30.5K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$24.3K |
| 5 |
HF
HRT Financial
New York
|
+$21K |
Top Sellers
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$1.36M |
| 2 |
Axa
Paris,
France
|
-$375K |
| 3 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$233K |
| 4 |
CF
Cantor Fitzgerald
New York
|
-$88.5K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$53.5K |
